Correlation Engine 2.0
Clear Search sequence regions


  • bacteria (4)
  • DnaK (1)
  • gram (3)
  • polymyxin (1)
  • polymyxin b (4)
  • salmonella (1)
  • Sizes of these terms reflect their relevance to your search.

    Polymyxin B, used to treat infections caused by antibiotic-resistant Gram-negative bacteria, produces nephrotoxicity at its current dosage. We show that a combination of nonbactericidal concentration of this drug and lysophosphatidylcholine (LPC) potently inhibits growth of Salmonella and at least two other Gram-negative bacteria in vitro This combination makes bacterial membrane porous and causes degradation of DnaK, the regulator of protein folding. Polymyxin B-LPC combination may be an effective and safer regimen against drug-resistant bacteria. Copyright © 2020 American Society for Microbiology.

    Citation

    Jitender Yadav, Sana Ismaeel, Ayub Qadri. Lysophosphatidylcholine Potentiates Antibacterial Activity of Polymyxin B. Antimicrobial agents and chemotherapy. 2020 Nov 17;64(12)

    Expand section icon Mesh Tags

    Expand section icon Substances


    PMID: 32988824

    View Full Text